Figures & data
Table 1. Clinical data of patients with EPS who were treated with mTOR inhibitors.
Rajani R, Smyth J, Koffman CG, Abbs I, Goldsmith DJ. Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. Nephrol Dial Transplant. 2002;17:2278–2280. Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: Treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24:3209–3215. Mohamed AO, Kamar N, Nogier MB, Esposito L, Duffas JP, Rostaing L. Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection. Exp Clin Transplant. 2009;7:164–167. Temple S, Zaltzman J, Perl J. Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy. Perit Dial Int. 2010;30:475–477. Adamidis KN, Zachariou CA, Kopaka ME, et al. Sclerosing peritonitis presenting 2 years after renal transplantation in a former CAPD patient. Ren Fail. 2011;33:246–248. Huddam B, Azak A, Koçak G, Başaran M, Voyvoda N, Duranay M. Additive effectiveness of everolimus plus tamoxifen therapy in treatment of encapsulating peritoneal sclerosis. Ren Fail. 2012;34:387–389. da Silva N, Rocha S, Rocha L, Faria S, Costa T, Mota C. Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient. Pediatr Nephrol. 2012;27:1583–1588. Debska-Slizien A, Konopa J, Januszko-Giergielewicz B, et al. Posttransplant encapsulating peritoneal sclerosis: Presentation of cases and review of the literature. J Nephrol. 2013;26:906–911. Sud R, Garry L, Spicer ST, et al. A role for everolimus in post‐transplant encapsulating peritoneal sclerosis: First case report. Nephrology. 2014;19:27–30. Romagnoli J, Pedroso JA, Salerno MP, Favi E, Spagnoletti G, Citterio F. Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: A case report. Transplant Proc. 2014;46:2368–2370. Frascà GM, D’Arezzo M, Ricciatti AM, et al. m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS). J Nephrol. 2014;27:587–590. Messina M, Ariaudo C, Mella A, Cantaluppi V, Segoloni GP, Biancone L. mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: A favourable single center experience. J Nephrol. 2015;28:245–249. Pozdzik AA, Fernandez V, Demetter P, et al. Encapsulating peritoneal sclerosis in a kidney graft recipient unmaskedödöd by everolimus switch. Perit Dial Int. 2015;35:769–771.